SCLC, recurrent

Clinical trials for SCLC, recurrent explained in plain language.

Never miss a new study

Get alerted when new SCLC, recurrent trials appear

Sign up with your email to follow new studies for SCLC, recurrent, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Two-Drug combo targets Hard-to-Treat recurrent small cell lung cancer

Disease control Not yet recruiting

Researchers are testing a combination of paclitaxel polymeric micelles and ivonescimab in adults with small cell lung cancer that has returned or stopped responding after platinum-based chemotherapy and anti-PD-1/PD-L1 therapy. The phase 2 trial aims to see how many participants'…

Matched conditions: SCLC, RECURRENT

Phase 2 • Sponsor: Shaodong Hong • Aim: Disease control

Last updated Sep 17, 2026 00:00 UTC

SCLC, recurrent

Get alerted when new SCLC, recurrent trials appear

Two-Drug combo targets Hard-to-Treat recurrent small cell lung cancer